Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 38

1.

Thermoreversible gel formulation containing sodium lauryl sulfate as a potential contraceptive device.

Haineault C, Gourde P, Perron S, Désormeaux A, Piret J, Omar RF, Tremblay RR, Bergeron MG.

Biol Reprod. 2003 Aug;69(2):687-94. Epub 2003 Apr 30.

PMID:
12724280
2.

Protein-rich diet attenuates cyclosporin A-induced renal tubular damage in rats.

Pons M, Plante I, LeBrun M, Gourde P, Simard M, Grenier L, Thibault L, Labrecque G, Beauchamp D.

J Ren Nutr. 2003 Apr;13(2):84-92.

PMID:
12671830
3.

Thermoreversible gel as a candidate barrier to prevent the transmission of HIV-1 and herpes simplex virus type 2.

Piret J, Gagné N, Perron S, Désormeaux A, Tremblay MJ, Gourde P, Omar RF, Bergeron AM.

Sex Transm Dis. 2001 Aug;28(8):484-91.

PMID:
11473223
4.

Thermoreversible gel formulations containing sodium lauryl sulfate or n-Lauroylsarcosine as potential topical microbicides against sexually transmitted diseases.

Roy S, Gourde P, Piret J, Désormeaux A, Lamontagne J, Haineault C, Omar RF, Bergeron MG.

Antimicrob Agents Chemother. 2001 Jun;45(6):1671-81.

5.

Sterically stabilized liposomes bearing anti-HLA-DR antibodies for targeting the primary cellular reservoirs of HIV-1.

Bestman-Smith J, Gourde P, Désormeaux A, Tremblay MJ, Bergeron MG.

Biochim Biophys Acta. 2000 Sep 29;1468(1-2):161-74.

6.

Sodium lauryl sulfate increases the efficacy of a topical formulation of foscarnet against herpes simplex virus type 1 cutaneous lesions in mice.

Piret J, Désormeaux A, Cormier H, Lamontagne J, Gourde P, Juhász J, Bergeron MG.

Antimicrob Agents Chemother. 2000 Sep;44(9):2263-70.

7.

Infection of primary human monocytes by Epstein-Barr virus.

Savard M, Bélanger C, Tardif M, Gourde P, Flamand L, Gosselin J.

J Virol. 2000 Mar;74(6):2612-9.

8.

In vitro and in vivo evaluations of sodium lauryl sulfate and dextran sulfate as microbicides against herpes simplex and human immunodeficiency viruses.

Piret J, Lamontagne J, Bestman-Smith J, Roy S, Gourde P, Désormeaux A, Omar RF, Juhász J, Bergeron MG.

J Clin Microbiol. 2000 Jan;38(1):110-9.

9.
10.

Reducing chorioretinal viral counts with intravitreal foscarnet injections in a rabbit model of Herpes simplex virus type-1 retinitis.

Morin NJ, Delorme C, Gourde P, Omar RF, Désormeaux A, Tremblay MJ, Beauchamp D, Rousseau A, Bergeron MG.

J Ocul Pharmacol Ther. 1999 Oct;15(5):465-77.

PMID:
10530708
11.

Targeting lymph nodes with liposomes bearing anti-HLA-DR Fab' fragments.

Dufresne I, Désormeaux A, Bestman-Smith J, Gourde P, Tremblay MJ, Bergeron MG.

Biochim Biophys Acta. 1999 Oct 15;1421(2):284-94.

12.

Effectiveness and toxicity of gentamicin in an experimental model of pyelonephritis: effect of the time of administration.

LeBrun M, Grenier L, Gourde P, Bergeron MG, Labrecque G, Beauchamp D.

Antimicrob Agents Chemother. 1999 May;43(5):1020-6.

13.

Protective effect of a thermoreversible gel against the toxicity of nonoxynol-9.

Gagné N, Cormier H, Omar RF, Désormeaux A, Gourde P, Tremblay MJ, Juhász J, Beauchamp D, Rioux JE, Bergeron MG.

Sex Transm Dis. 1999 Mar;26(3):177-83.

PMID:
10100776
14.

Epstein-Barr virus infects and induces apoptosis in human neutrophils.

Larochelle B, Flamand L, Gourde P, Beauchamp D, Gosselin J.

Blood. 1998 Jul 1;92(1):291-9.

15.

Intracellular and serum stability of liposomal 2',3'-dideoxycytidine. Effect of lipid composition.

Makabi-Panzu B, Gourde P, Désormeaux A, Bergeron MG.

Cell Mol Biol (Noisy-le-grand). 1998 Mar;44(2):277-84.

PMID:
9593578
16.

Time-restricted feeding schedules modify temporal variation of gentamicin experimental nephrotoxicity.

Beauchamp D, Guimont C, Grenier L, LeBrun M, Tardif D, Gourde P, Bergeron MG, Thibault L, Labrecque G.

Antimicrob Agents Chemother. 1997 Jul;41(7):1468-74.

17.

Attenuation of gentamicin-induced nephrotoxicity in rats by fleroxacin.

Beauchamp D, Laurent G, Grenier L, Gourde P, Zanen J, Heuson-Stiennon JA, Bergeron MG.

Antimicrob Agents Chemother. 1997 Jun;41(6):1237-45.

18.

Antiviral efficacy and toxicity of ribavirin and foscarnet each given alone or in combination in the murine AIDS model.

Omar RF, Harvie P, Gourde P, Désormeaux A, Tremblay M, Beauchamp D, Bergeron MG.

Toxicol Appl Pharmacol. 1997 Mar;143(1):140-51.

PMID:
9073602
19.

Ribavirin potentiates the efficacy and toxicity of 2',3'- dideoxyinosine in the murine acquired immunodeficiency syndrome model.

Harvie P, Omar RF, Dusserre N, Lansac N, Désormeaux A, Gourde P, Simard M, Tremblay M, Beauchamp D, Bergeron MG.

J Pharmacol Exp Ther. 1996 Nov;279(2):1009-17.

PMID:
8930211
20.

Antiviral efficacy and toxicity of ribavirin in murine acquired immunodeficiency syndrome model.

Harvie P, Omar RF, Dusserre N, Désormeaux A, Gourde P, Tremblay M, Beauchamp D, Bergeron MG.

J Acquir Immune Defic Syndr Hum Retrovirol. 1996 Aug 15;12(5):451-61.

PMID:
8757421
21.

In vivo toxicity of foscarnet and zidovudine given alone or in combination.

Omar RF, Gourde P, Désormeaux A, Tremblay M, Beauchamp D, Bergeron MG.

Toxicol Appl Pharmacol. 1996 Aug;139(2):324-32.

PMID:
8806849
22.

Temporal variation in nephrotoxicity of low doses of isepamicin in rats.

Yoshiyama Y, Grenier L, Gourde P, Simard M, Lin L, Morin NJ, Bergeron MG, Labrecque G, Beauchamp D.

Antimicrob Agents Chemother. 1996 Mar;40(3):802-6.

23.

Nephrotoxicity of amphotericin B in rats: effects of the time of administration.

LeBrun M, Grenier L, Gourde P, Bergeron MG, Labrecque G, Beauchamp D.

Life Sci. 1996;58(11):869-76.

PMID:
8786692
24.

L-651,392, a potent leukotriene inhibitor, controls inflammatory process in Escherichia coli pyelonephritis.

Tardif M, Beauchamp D, Bergeron Y, Lessard C, Gourde P, Bergeron MG.

Antimicrob Agents Chemother. 1994 Jul;38(7):1555-60.

25.

Ceftriaxone protects against tobramycin nephrotoxicity.

Beauchamp D, Thériault G, Grenier L, Gourde P, Perron S, Bergeron Y, Fontaine L, Bergeron MG.

Antimicrob Agents Chemother. 1994 Apr;38(4):750-6.

26.

Daptomycin may attenuate experimental tobramycin nephrotoxicity by electrostatic complexation to tobramycin.

Couture M, Simard M, Gourde P, Lessard C, Gurnani K, Lin L, Carrier D, Bergeron MG, Beauchamp D.

Antimicrob Agents Chemother. 1994 Apr;38(4):742-9.

27.

Subcellular distribution of daptomycin given alone or with tobramycin in renal proximal tubular cells.

Beauchamp D, Gourde P, Simard M, Bergeron MG.

Antimicrob Agents Chemother. 1994 Feb;38(2):189-94.

28.

Nephrotoxicity of low doses of tobramycin in rats: effect of the time of administration.

Lin L, Grenier L, Thériault G, Gourde P, Yoshiyama Y, Bergeron MG, Labrecque G, Beauchamp D.

Life Sci. 1994;55(3):169-77.

PMID:
8007759
29.
30.

Effect of beta-lactams on peptidoglycan metabolism of Haemophilus influenzae grown in animals.

Rousseau N, Dargis M, Gourde P, Beauchamp D, Malouin F.

Antimicrob Agents Chemother. 1992 Oct;36(10):2147-55.

32.

Molecular basis of the non-beta-lactamase-mediated resistance to beta-lactam antibiotics in strains of Haemophilus influenzae isolated in Canada.

Clairoux N, Picard M, Brochu A, Rousseau N, Gourde P, Beauchamp D, Parr TR Jr, Bergeron MG, Malouin F.

Antimicrob Agents Chemother. 1992 Jul;36(7):1504-13.

33.

Age-dependent gentamicin experimental nephrotoxicity.

Beauchamp D, Gourde P, Thériault G, Bergeron MG.

J Pharmacol Exp Ther. 1992 Feb;260(2):444-9.

PMID:
1738093
34.

Subcellular distribution of gentamicin in proximal tubular cells, determined by immunogold labeling.

Beauchamp D, Gourde P, Bergeron MG.

Antimicrob Agents Chemother. 1991 Nov;35(11):2173-9.

35.

Prolonged endotoxemia enhances the renal injuries induced by gentamicin in rats.

Auclair P, Tardif D, Beauchamp D, Gourde P, Bergeron MG.

Antimicrob Agents Chemother. 1990 May;34(5):889-95.

36.

Endotoxin increases the nephrotoxic potential of gentamicin and vancomycin plus gentamicin.

Ngeleka M, Beauchamp D, Tardif D, Auclair P, Gourde P, Bergeron MG.

J Infect Dis. 1990 Apr;161(4):721-7.

PMID:
2181033
37.

Effects of daptomycin and vancomycin on tobramycin nephrotoxicity in rats.

Beauchamp D, Pellerin M, Gourde P, Pettigrew M, Bergeron MG.

Antimicrob Agents Chemother. 1990 Jan;34(1):139-47.

38.

Effect of age on the intracortical accumulation kinetics of gentamicin in rats.

Beauchamp D, Gourde P, Bergeron MG.

Antimicrob Agents Chemother. 1989 Nov;33(11):2006-8.

Supplemental Content

Loading ...
Support Center